[1] 韩焕钦, 欧进军, 冯冰,等. 尿IGFBP7及TIMP-2在失代偿期乙型肝炎肝硬化急性肾损伤中的应用价值. 中华肝脏病杂志, 2020, 28(9):760-765. [2] 林岩, 闫军, 张其玉,等. 失代偿期肝硬化合并胆总管结石患者行十二指肠镜治疗的安全和有效性分析. 中华消化内镜杂志, 2019, 36(6):416-421. [3] 徐升, 徐芳, 应丽园,等. 肝硬化合并上消化道出血患者医院感染的病原学特点及影响因素研究. 中华医院感染学杂志, 2019, 29(1):71-74. [4] 杨晓玲, 张素梅. SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析. 实用肝脏病杂志, 2020, 23(1):70-73. [5] Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelinesfor peptic ulcer disease 2015. J Gastroenterol, 2016, 51(3):177-194. [6] 中华人民共和国卫生部. 医院感染监测规范. 中华医院感染学杂志, 2009, 19(11):1-2. [7] Morais R, Liberal R, Santos A, et al. Another clinical unmet need in liver patients: Multidrug resistant bacteria in decompensated cirrhosis. J Hepatol, 2019,71(4):844-845. [8] Virendra A, Singh H, Akash E, et al. Midodrine and albumin in decompensated cirrhosis: Down but not out. J Hepatol, 2019, 70(4):811-811. [9] Gupta T, Lochan D, Verma N, et al. Presence of multidrug-resistant infections at admission predict 28-day mortality in acute decompensation of cirrhosis.J Gastroenterol Hepatol, 2020, 35(3):461-466. [10] Ventura E, Zeneroli M L . Concentration-reinfusion (CR) of ascitic of ascitic fluid in the treatment of decompensated liver cirrhosis with diuretic-resistant ascites. Postgrad Med J, 2019, 51(598):577-580. [11] 唐飞, 王凤梅, 吕洪敏,等. IL-6,hs-CRP及Hsp70诊断肝硬化患者幽门螺杆菌感染的价值. 中华医院感染学杂志, 2020, 30(16):2416-2420. [12] Sharon ST, Levy G, Didier L, et al. Prevention of decompensation incirrhosis: a new youth for β blockers. Lancet, 2019, 393(10181):1571-1572. [13] 周小兵, 李玉鑫, 高方媛,等. 肝硬化合并自发性细菌性腹膜炎133例的危险因素分析. 中华消化杂志, 2019, 39(4):268-270. [14] 姜雪锦, 孙吉花. 基于倾向指数匹配的医院感染直接经济损失评价. 中华医院感染学杂志, 2018, 20(8):1237-1240. [15] Wang GX, Shen LX, Gao YP, et al. Primary medullary hemorrhage in a patient with coagulopathy due to alcoholic cirrhosis: A case report. Medicine (Baltimore), 2018, 97(14):29-31. [16] Preda C M, Popescu C P, Baicus C, et al. Risk of HBV reactivation in HBV+HCV coinfected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/dasabuvir+ribavirin. J Viral Hepat, 2018, 25(7):834-841. [17] 杨慧玲, 刘小静, 何英利,等. 失代偿期乙型肝炎肝硬化患者发生医院感染临床特点及危险因素分析. 实用肝脏病杂志, 2020, 23 (1):78-81. [18] Zaccherini G, Baldassarre M, Bartoletti M, et al. Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admittedto hospital with acute decompensation. J Hep Rep, 2019, 1(4):270-277. |